DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Antibody diversity is critical for the generation of a protective immune response. Early B cell precursors generate antigen recognition diversity by assembling immunoglobulin (Ig) variable-region V(D)J exons from individual variable (V), diversity (D) and joining (J) gene segments through recombination-activating gene 1 (RAG-1) and RAG-2 proteins 1 . Mature B cells functionally diversify the antibody repertoire through two antigen-dependent processes that usually occur in the germinal center (GC) of secondary lymphoid organs. These are Ig V(D)J gene somatic hypermutation, which increases the antibody affinity for antigen by introducing point mutations within the V(D)J exon, and Ig heavy chain (H) class switching, which modulates the antibody effector functions by substituting the constant region of IgM with that of IgG, IgA or IgE [2] [3] [4] . Hypermutated and class-switched GC B cells either give rise to long-lived memory B cells or terminally differentiate to plasma cells, which secrete large amounts of antibodies.
Class switching is mediated by class switch DNA recombination (CSR). CSR replaces the Ig heavy chain constant region Cµ gene with a targeted Cγ, Cα or Cε gene by recombining the switch region µ (Sµ), a highly repetitive DNA segment 5′ of Cµ, with an analogous Sγ, Sα or Sε region 5′ of the targeted CH gene 2, 4 . Most antigens, including complex viral and bacterial proteins, elicit CSR in GC B cells by up-regulating the tumor necrosis factor (TNF) family member CD40 ligand (CD40L) on CD4 + T cells 2, 5 . By activating the IH promoter, a regulatory DNA sequence that includes a noncoding IH exon located 5′ of each S region, engagement of CD40 on B cells by CD40L induces germline IH-CH transcription, which increases the accessibility of the targeted S region to the CSR machinery 2, 4 . This as yet elusive enzymatic complex includes activation-induced cytidine deaminase (AID), a B cell-specific and CD40-inducible RNA-editing enzyme, and initiates CSR by promoting deletion of intervening IgH DNA between Sµ and the targeted S region 4, 6 . CSR is thought to be highly dependent on CD40L, as IgG, IgA and IgE production is severely impaired in the X-linked hyper-IgM syndrome 7 . However, viral glycoproteins and bacterial polysaccharides can stimulate IgG and IgA production in the absence of CD40L-expressing CD4 + T cells 2, [8] [9] [10] [11] . This implies the existence of CSR-inducing molecules different from CD40L. Unlike T cell-dependent (TD) class switching, T cell-independent (TI) class switching occurs in splenic marginal zone or intestinal lamina propria B cells and provides prompt protection against invading pathogens 10, 11 . The requirements and modalities of TI class switching remain obscure. Antigen-presenting cells (APCs) interact with B cells to enhance IgG and IgA production 12 ; this led us to hypothesize that APCs play a key role in the initiation of CD40-independent CSR.
APCs, including dendritic cells (DCs), monocytes and macrophages, express the B lymphocyte stimulator protein (BLyS, also known as BAFF, TALL-1, THANK and zTNF4) 13, 14 . This TNF family member binds to three receptors selectively expressed by B cells, including transmembrane activator and calcium modulator and cyclophylin ligand interactor (TACI), B cell maturation antigen (BCMA) and BAFF receptor (BAFF-R also known as BR3) [15] [16] [17] [18] [19] . APCs express a second ligand, a proliferation-inducing ligand (APRIL), which binds with high affinity to BCMA and with lower affinity to TACI but not to BAFF-R 20, 21 . Engagement of TACI, BCMA and BAFF-R by BLyS activates a CD40-like pathway that enhances B cell survival by up-regulating the antiapoptotic molecules NF-κB and Bcl-2 22 . Unlike CD40L deficiency, which impairs TD but not TI IgGand IgA responses 23, 24 , BLyS deficiency impairs both TD and TI IgG and IgA production 25 . A similar phenotype can be induced by overexpressing TACI-Ig and BCMA-Ig, two soluble decoy receptors that neutralize BLyS and APRIL [15] [16] [17] [18] 26, 27 . Conversely, BLyS overexpression increases IgG, IgA and IgE and leads to a systemic lupus erythematosus (SLE)-like syndrome with kidney deposition of IgG and IgA 17, 28 . Finally, APRIL overexpression enhances IgG production in response to TI but not TD antigens 29 . These findings indicate that BLyS and APRIL up-regulate class-switched Igs, but offer no clue as to whether this up-regulation stems only from the accumulation of terminally differentiated B cells or derives also from enhanced CSR in IgD + and/or IgM + B cells. We show here that human DCs and monocytes up-regulate BLyS and APRIL upon stimulation with interferon-α (IFN-α), IFN-γ, lipopolysaccharide (LPS) or CD40L. In the presence of appropriate cytokines, BLyS and APRIL induce CD40-independent CSR to Cγ, Cα or Cε in B cells. These cells further differentiate to plasmacytoid cells that secrete class-switched antibodies upon B cell antigen receptor (BCR) engagement and exposure to IL-15.
Results

BLyS and APRIL induce CSR
CSR generates an extrachromosomal reciprocal switch DNA recombination product, switch circle (SC), which includes the IH promoter 5′ of the targeted CH gene, the DNA segment between Sµ and the targeted S region, and Cµ (Fig. 1a) . Under the influence of the IH promoter, the SC transcribes a chimeric I-Cµ product, referred as circle transcript (CT) 30 . Together with AID, SCs and CTs constitute highly specific markers of ongoing CSR 30 . These markers were used to evaluate the CSR-inducing activity of BLyS and APRIL in human IgD + B cells, which, before stimulation, express unrearranged Sµ, Sγ, Sα and Sε regions 2, 31 . BLyS and APRIL were used together with cytokines with known CSR-inducing activity. These cytokines included interleukin 10 (IL-10), a B cell-and APC-derived cytokine that induces switching to IgG1, IgG3, IgA1 and IgA2 2, 12 ; IL-4, a T cell-derived cytokine that induces switching to IgG1, IgG2, IgG3, IgG4, IgA1, IgA2 and IgE 31 ; and transforming growth factor-β1 (TGF-β1), a B cell-and APCderived cytokine that inudces switching to IgA1 and IgA2 2,12 . (Fig. 1b) and weakly expressed Iγ1 and Iγ2 (Iγ1/2)-Cµ, Iγ3-Cµ and Iα1/2-Cµ CTs as well as AID transcripts (Fig. 1c) . (Fig. 2) .
Additional experiments compared the CSR-inducing activity of BLyS and APRIL with that of other TNF family members. IgD + B cells exposed to BLyS or APRIL and IL-4 up-regulated total Sγ-Sµ and Sα-Sµ SCs, although at lower amounts compared to IgD + B cells stimulated with CD40L and IL-4 (Fig. 3a) . In contrast, IgD + B cells stimulated with TNF-α or lymphotoxin-α (LT-α), which are critically involved in the GC reaction 32 , did not contain SCs. Finally, dose-response experiments showed that, when combined with IL-4, BLyS and APRIL induce CSR at concentrations as low as 1 ng/ml (Fig. 3b) . These results indicated that, in the presence of appropriate cytokines, BLyS and APRIL induce CD40-independent CSR to Cγ, Cα or Cε genes.
BLyS and APRIL up-regulate I H -C H transcripts
Germline IH-CH transcription increases the accessibility of the targeted S region 5′ of the CH gene to the CSR machinery 2, 4 . After CSR is completed, the targeted CH gene is juxtaposed to the recombined VHDJH exon to form a VHDJH-CH transcript that is subsequently translated into an Ig protein ( 
BCR enhances BLyS-or APRIL-induced NF-κB
In addition to playing a central role in B cell proliferation and survival, NF-κB-Rel induces germline IH-CH transcription by activating the CD40 responsive element (RE) within the targeted IH promoter 2, 33 . Compared to IgD + B cells exposed to medium alone, IgD + B cells incubated with BLyS or APRIL up-regulated the binding of NF-κB-Rel to the CD40 RE of the germline Cγ3 gene promoter (Fig. 4b) . NF-κB was also activated by BCR engagement, although to a lesser extent than BLyS or APRIL. Consistent with the critical role of antigen in TI antibody production 34 and with the ability of BLyS and APRIL to increase the proliferation and differentiation of BCR-activated B cells 14, 35 , BCR engagement enhanced the activation of NF-κB by BLyS or APRIL.
Further experiments established that BLyS and APRIL induce the nuclear translocation of similar NF-κB-Rel complexes, including p50-p65 and p50-c-Rel complexes (Fig. 4c) . Smaller amounts of p50-p50 complexes were also detectable (data not shown). In BLyS-stimulated B cells, NF-κB activation was comparably inhibited by soluble TACI-Ig and BCMA-Ig decoy receptors (Fig. 4d) , which bind to BLyS with high affinity 17, 26 . In APRIL-stimulated B cells, NF-κB activation was inhibited by BCMA-Ig, which binds to APRIL with high affinity, and, to a lesser extent, by TACI-Ig, which binds to APRIL with lower affinity than BCMA-Ig 20, 26 . As expected, a neutralizing antibody to soluble BLyS interfered with the activation of NF-κB induced by BLyS but not with that induced by APRIL. These experiments showed that both BLyS and APRIL activate NF-κB-Rel in human B cells. This activation was further up-regulated by BCR engagement and could be specifically inhibited by soluble BLyS and APRIL decoy receptors. (Fig. 5a) . These cells or B cells exposed to BLyS or APRIL alone did not secrete IgG and IgA (data not shown), unless further stimulated through BCR cross-linking (Fig. 5b) . IgG and IgA production was further enhanced by IL-15 (Fig. 5b) or IL-2 (data not shown), two inducers of antibody secretion produced by APCs and T cells, respectively 36, 37 . In BLySstimulated B cells, IgG and IgA secretion was comparably inhibited by soluble TACI-Ig and BCMA-Ig. In APRIL-stimulated B cells, IgG and IgA secretion was inhibited by BCMA-Ig and to a lesser extent by TACI-Ig. Thus, BCR cross-linking and IL-15 are necessary to stimulate the secretion of class switched antibodies by BLyS-or APRIL-activated B cells.
IFN, CD40L or LPS induce BLyS and APRIL
After the capture of viral or bacterial antigens, DCs express IFN-α, a type I IFN that, in addition to possessing antiviral activity, critically modulates both TD and TI immune responses, including Ig class switching 38, 39 . A similar effect is elicited by IFN-γ, a type II IFN expressed by several cell types, including APCs, natural killer (NK) cells and T cells 2, 38 . Given the key roles of both IFN-α and IFN-γ in DC activation and differentiation [40] [41] [42] , we hypothesized that IFNs modulate Ig class switching by up-regulating the expression of BLyS and APRIL in DCs. Compared to DCs incubated with medium alone, DCs incubated with IFN-α or IFN-γ up-regulated BLyS and APRIL transcripts, total BLyS and APRIL proteins, soluble BLyS as well as membranebound BLyS (Fig. 6) . Similar up-regulation was induced by CD40L, another critical modulator of DC activation, maturation and survival 41 . Like DCs, monocytes up-regulated soluble and membrane-bound BLyS after stimulation with IFN-α, IFN-γ or bacterial LPS (Fig. 7a) . These findings indicated that both innate and T cell-derived immune modulators enhance the expression of BLyS and APRIL.
DCs induce CSR through BLyS and APRIL
DCs play an key role in the modulation of CD40-dependent Ig class switching 12, 41 . To verify whether APCs induce CD40-independent class switching through BLyS and APRIL, DCs or monocytes were first activated with CD40L, IFN-γ, IFN-α or LPS, then washed and exposed to IgD + B cells. Compared to IgD + B cells incubated with medium alone or control epithelial cells, IgD + B cells incubated with unstimulated DCs or unstimulated monocytes contained small amounts of Iγ1/2-Cµ, Iγ3-Cµ_ and Iα1/2-Cµ CTs and AID transcripts (Figs. 6d and 7b) . All these markers of CSR were up-regulated by culturing IgD + B cells with activated DCs (Fig. 6d) , activated monocytes (Fig. 7b) or culture fluids from monocytes incubated with IFN-γ (Fig. 7c) . Activated DCs and monocytes induced CSR in a BLyS and APRIL-dependent but CD40-independent manner; up-regulation of CTs and AID was inhibited by BCMA-Ig and, to a lesser extent, by TACI-Ig or a neutralizing antibody to soluble BLyS (Figs. 6d and 7b,c) . DC-and monocyte-induced CSR was also partially inhibited by neutralizing antibodies to IL-10 or TGF-β (data not shown), but not by a control mouse IgG1 or CD40-Ig, a soluble inhibitor of CD40L-CD40 interaction (Figs. 6d and 7b,c) . These findings indicated that APCs elicit CD40-independent CSR to Cγ and Cα through both BLyS and APRIL.
DCs induce IgG and IgA through BLyS and APRIL
B cells undergoing terminal plasmacytoid differentiation up-regulate CD38 and syndecan-1 (also known as CD138), down-regulate CD20 and accumulate cytoplasmic Igs that are subsequently secreted 36 . In the absence of BCR engagement, IgD + B cells exposed to resting or activated DCs did not secrete IgG and IgA (data not shown). In the presence of BCR engagement, IgD + B cells incubated with CD40L-, IFN-γ-or IFN-α-activated DCs but not with resting DCs or control epithelial cells secreted IgG and IgA (Fig. 8a) . This secretion occurred in a BLyS and APRIL-dependent but CD40-independent manner; it was inhibited by BCMA-Ig and, to a lesser extent, by TACI-Ig or a neutralizing antibody to soluble BLyS, but not by a control IgG1 or CD40-Ig. DC-induced IgG and IgA secretion was also dependent on IL-15, as it was severely inhibited by a neutralizing antibody to this cytokine. In addition to secreting IgA and IgG, IgD + B cells exposed to activated DCs accumulated cytoplasmic IgA (Fig. 8b-d) and IgG (data not shown), down-regulated CD20 and up-regulated CD38 and syndecan-1 (Fig.  8e-g ). Again, these plasmacytoid phenotypic traits were induced in a BLyS and APRIL-dependent but CD40-independent manner; they were inhibited by BCMA-Ig but not by CD40-Ig. Thus, APCs induced CD40-independent IgG and IgA secretion by expressing BLyS, APRIL and cytokines, including IL-15. 8, [9] [10] [11] . TI IgM and IgG production occurs mainly in CD5 -B2 cells lodged in the splenic marginal zone and is critical in the clearance of blood-borne pathogens, as indicated by the high frequency of infections by encapsulated bacteria after splenectomy [9] [10] [11] . TI IgA production occurs in CD5 + B1 cells in the intestinal lamina propria and is critical in the elimination of pathogens and prevention of the systemic penetration of dietary antigens and commensal bacteria [9] [10] [11] 43 . Our findings indicate that TI class switching to IgG and IgA may be initiated by DCs and macrophages through BLyS and APRIL.
DCs and macrophages in the splenic marginal zone and intestinal mucosa sample and retain TI antigens 10, 11, 44 . Antigen capture would initiate TI Ig class switching by triggering the secretion of IFN-α [40] [41] [42] , a type I IFN that up-regulates the expression of BLyS and APRIL in APCs. In the presence of IL-4, IL-10 or TFG-β produced by marginal zone or intestinal APCs, stromal cells and/or mast cells, BLyS and APRIL would induce CD40-independent CSR to Cγ, Cα and even Cε 45 in IgD + and/or IgM + B cells. This model is consistent with published studies showing that IFN-α-activated DCs trigger TI class switching to all IgG subclasses in mice 38 and enhance IgG and IgA secretion in patients with SLE 39 . A similar DC-mediated BLyS and APRIL-dependent mechanism may also underlie the induction of TI class switching by IFN-γ or bacterial LPS 2, 8, 9 .
Although it plays a central role in TI antibody production 8, 34 , BCR crosslinking is not required to initiate CSR in BLyS-or APRIL-activated B cells. Consistent with this, TI switching to IgA can occur without previous expression of surface IgM or IgD . Unlike these mice, BCMA-deficient mice lack an overt phenotype, which suggests a redundant role for BCMA 25 . In addition, BAFF-R-deficient mice and A/WySnJ mice, which express a disrupted BAFF-R, show fewer B cells as well as impaired TI IgG production 19, 25 . Thus, TI CSR may result from the combined activation of TACI and BAFF-R. These CD40-like receptors induce nuclear translocation of NF-κB 15, 47, 48 , which might activate Iγ and Iε gene promoters by cooperating with IL-4 receptor-induced signal transducer and activator of transcription 6 (STAT6), and Iα gene promoters by cooperating with TGF-β receptor-induced Smad proteins . The persistence of TI IgG and IgA production in CD40L-deficient mice 23, 24 could be due to the ability of TI antigens to up-regulate BLyS and APRIL through IFN-α and LPS. Finally, by showing that BLyS and APRIL are up-regulated by T cell CD40L and IFN-γ, and-together with T cell IL-4-induce CSR to Cγ, Cα and Cε genes, our findings further emphasize that BLyS and APRIL critically amplify TD Ig class switching. Thus, TACI-Ig, BCMA-Ig or antagonistic antibodies to BLyS and APRIL could be used to attenuate abnormal switching to IgG, IgA and/or IgE in autoimmune and allergic disorders, including SLE, rheumatoid arthritis and asthma.
Methods
Cells. Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats purchased from the New York Blood Bank. IgD+ B cells were purified from PBMCs as described 33, 49 . CD14 + monocytes were magnetically sorted from PBMCs with a fluorescein (FITC)-conjugated antibody to CD14 (Serotec, Raleigh, NC) and anti-FITC microbeads (Miltenyi Biotec, Auburn, CA). To obtain CD83 + DCs, purified monocytes were stimulated for 7 days with granulocyte monocyte-colony stimulating factor (GM-CSF, 50 ng/ml, R&D Systems, Minneapolis, MN), IL-4 (250 U/ml, Schering-Plough, Kenilworth, NJ) and monocyte-derived conditioned medium 50 Reagents. Human BLyS (Human Genome Sciences, Rockville, MD), APRIL MegaLigand (Alexis Biochemicals, San Diego, CA) and trimeric CD40L (Immunex, Seattle, WA) were used at 1 µg/ml. Human IL-10 (200 ng/ml, Schering-Plough), TGF-β (0.5 ng/ml), TNF-α (25 ng/ml), LT-α (25 ng/ml), IFN-α2a (50 U/ml), IFN-γ (50 U/ml, R&D Systems), IL-15 (100 ng/ml, Sigma, St. Louis, MO) and LPS from Escherichia Coli serotype 026:B6 (1 µg/ml, Sigma) were also used. Mouse IgG1 control MOPC-21 (Sigma), TACI-Ig, BCMAIg, the mouse IgG1 neutralizing 15C10 monoclonal antibody (mAb) to soluble BLyS (Human Genome Sciences) and CD40-Ig (Ancell, Bayport, MN) were used at 30 µg/ml. To simulate BCR engagement by a polyvalent TI antigen, B cells were exposed to 2 µg/ml of Immunobead Reagent (Irvine Scientifics, Camarillo, CA), a solid phase antibody against human Ig 33, 49 .
Flow cytometry and fluorescence microscopy. CD14, CD20 (Sigma), CD38 (Pharmingen, San Diego, CA), CD83, syndecan-1 (Serotec) were detected with FITC-or phycoerythrin (PE)-conjugated antibodies. Membrane-bound BLyS was labeled with the biotinylated antibody 9B6 (Human Genome Sciences) and PE-conjugated streptavidin (PharMingen) 35 . Cells were acquired with a FACScalibur analyzer (Becton Dickinson Immunocytometry Systems, San Jose, CA). To visualize cellular nuclei and cytoplasmic IgA, cells were centrifuged, fixed in methanol and labeled with 4',6-diamidine-2'-phenylindole dihydrochloride (Boehringer Mannheim, Indianapolis, IN) and a FITC-conjugated antibody to IgA (Sigma), respectively. Slides were analyzed with a fluorescence microscope Zeiss Axioplan 2 (Atto Instruments, Rockville, MD).
ELISAs. Supernatants from DCs or monocytes (5 × 10 6 /ml) were incubated overnight at 4°C on microplates coated with the capture mouse mAb 15C10 (IgG1) to human soluble BLyS (Human Genome Sciences). A biotinylated rabbit polyclonal antibody to mouse IgG (Human Genome Sciences), peroxidase streptavidin and the substrate 3,3′,5,5′-tetramethylbenzidine (Kirkegaard and Perry, Gaithersburg, MD) were used in sequential steps 35 . Readings were done at 450 nm. IgM, IgG, IgA and IgE were detected as described 33, 49 .
Genomic DNA PCRs. Genomic DNA was extracted from B cells with the QIAmp DNA Mini Kit (Qiagen, Valencia, CA). Total Sγ-Sµ SCs as well as Sγ1/2-Sµ, Sγ3-Sµ, Sγ4-Sµ, Sα1/2-Sµ and Sε-Sµ SCs were amplified from 500 ng of genomic DNA by a PCR strategy that included two nested forward primers that recognize IH and the 5′ segment of Sγ, Sα or Sε and two nested reverse primers that recognize distinct areas of the 3′ segment of Sµ 33, 49 . Due to their high degree of sequence identity, the Iγ1 and Iγ2 regions as well as the Iα1 and Iα2 regions were amplified with common Iγ1/2 and Iα1/2 primers, respectively. The conditions were denaturation 1 min at 94 °C, annealing 1 min at 68 °C and extension 4 min at 72 °C for two rounds of 30 cycles. Before each PCR, DNA was denaturated for 5 min at 94 °C. The identity of PCR products with SCs was confirmed by DNA sequencing. β-actin was amplified as reported.
RT-PCRs. cDNA was reverse transcribed (RT) from 3 µg of total RNA 33, 49 . PCRs were made semiquantitative by varying the number of amplification cycles and performing dilutional analysis so that there was a linear relationship between the amount of cDNA used and the intensity of the PCR product. Iγ1-Cγ1 (603 bp), Iγ2-Cγ2 (597 bp), Iγ3-Cγ3 (670 bp), Iγ4-Cγ4 (411 bp), Iα1-Cα1 (1,194 bp), Iα2-Cα2 (1,181 bp), VHDJH-Cγ1 (∼415 bp), VHDJH-Cγ2 (∼415 bp), VHDJH-Cγ3 (∼415 bp), VHDJH-Cγ4 (∼415 bp), VHDJH-Cα1 (∼900 bp), VHDJH-Cα2 (∼890 bp), VHDJH-Cε (∼200 bp), β-actin (593 bp) and Igβ (220 bp) were RT-PCR-amplified for 25 cycles as described 33, 49 . Iε-Cε (409), AID (382 bp), BLyS (398 bp) and APRIL (417 bp) were PCR-amplified for 25 cycles with the following primer pairs. Iε forward 5′-GACGGGCCACACCATCCACAGGCACCAAATGGACGAC-3′ and Cε reverse 5′-CAGGACGACTGTAAGATCTTCACG-3′; AID forward 5′-TGCTCTTCCTC-CGCTACATCTC-3′ and AID reverse 5′-AACCTCATACAGGGGCAAAAGG-3′; BLyS forward 5′-CAGCTCCAGGAGAAGGCAACT-3′ and BLyS reverse 5′-CAAT-GCCAGCTGAATAGCAGG-3′; APRIL forward 5′-GCCAGCCTCATCTCCTTTCTTG-3′ and APRIL reverse 5′-TGGTTGCCACATCACCTCTGTCAC-3′. Iγ1/2-Cµ (557 bp), Iγ3-Cµ (608 bp) Iγ4-Cµ (358 bp) Iα1/2-Cµ (666 bp) and Iε-Cµ (408 bp) CTs were RT-PCR-amplified for 25 cycles with the forward primers Iγ1/2 5′-GGGCTTCCAAGC-CAACAGGGCAGGACA-3′, Iγ3 5′-AGGTGGGCAGGCTTCAGGCACCGAT-3′, Iγ4 5′-TTGTCCAGGCCGGCAGCATCACCAGA-3′, Iα1/2 5′-CAGCAGCCCTCTTG-GCAGGCAGCCAG-3′ and Iε 5′-GAC GGGCCACACCATCCACAGGCACCAAATG-GACGAC-3′ together with the reverse primer Cµ 5′-GTTGCCGTTGGGGTGCTGGAC-3′. The PCR conditions were denaturation 1 min at 94 °C, annealing 1 min at 60 °C and extension 1 min at 72 °C.
Southern blots. PCR products were fractionated onto agarose gels, transferred overnight onto nylon membranes and hybridized with specific radiolabeled probes 33, 49 . SCs were hybridized with a probe that recognized the recombined Sµ region. Hybridization products appeared smeary on gel electrophoresis because CSR did not target a consensus DNA sequence, but it randomly occurred within a 1-10 kb S region. In each B cell, CSR yielded a single copy Sµ-SX SC with a size that ranged from 500-4,000 bp. CTs were hybridized with a probe that encompassed nucleotides 1-250 of the first Cµ exon. Two Iγ1/2-Cµ and Iα1/2-Cµ bands represented alternatively spliced forms, as reported 30 .
Immunoblots and electrophoretic mobility shift assays. Total proteins were obtained as described 49 , fractionated onto 10% SDS-PAGE and transferred to nitrocellulose membranes. After blocking, membranes were immunoblotted with antibodies to BLyS (Upstate Biotechnology, Lake Placid, NY), APRIL or actin (Santa Cruz Biotechnology, Santa Cruz, CA). Proteins were detected with an enhanced chemiluminescence detection system (Amersham, Little Chalfont, UK). Nuclear proteins were extracted as described 33, 49 and incubated with radiolabeled double stranded oligonucleotide probes that encompassed the κB1 site of the germline Cγ3 gene promoter. DNA binding reactions and inhibition assays with antibodies to p65, c-Rel, RelB, p50 or p52 (Santa Cruz Biotechnology) were done as described 33, 49 .
